Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes

NCT00624364 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart
DRUG: metformin

Sponsor

Novo Nordisk A/S